At Evotec, we help overcome one of the biggest challenges in cell therapy development: Transforming scientific innovation into real‑world impact by combining rigorous science, deep disease expertise, and solutions built to scale.  

We support cell therapy programs from concept to clinic through two complementary paths: Leveraging our industrialized iPSC platform and proprietary programs, and integrated CDMO solutions for cell therapy development and GMP manufacturing across all major cell therapy modalities. 

By uniting innovation, research, translational expertise, process development, and clinical‑grade production under one roof, we are shaping a future where cell therapies become more scalable, more accessible, and truly life‑changing for patients.

Contact Us to Learn More

Our Cell Therapy Offering & Competences

Turning Scientific Innovation into Scalable Cell Therapy Development

What sets Evotec apart is the ability to combine proprietary platform technologies with deep scientific expertise, enabling innovative cell therapy approaches and translating complex science into scalable, manufacturable therapies, across modalities and development stages. 

Five key differentiators of our cell therapy offering: integrated from discovery to manufacturing; expertise across cell therapy modalities; translating innovation into manufacturable therapies; built for scale and consistency; and partnership models tailored to your needs.

Proven Excellence Through Collaboration and Execution

Strategic collaborations, development milestones, and manufacturing achievements across multiple cell therapy modalities demonstrate the strength of our platform and our ability to advance innovative cell therapies toward clinical applications.

Explore our Expertise

Contact Our Cell Therapy Team

Our business model is flexible, ranging from service-based support to strategic partnerships.  Contact us to discuss your program needs.